Your Search Results

Left main and complex bifurcation stenting

21 May 2026 – From EuroPCR 2026

This focused session explores optimal strategies for treating left main and complex bifurcation coronary lesions, a setting that remains both anatomically and technically demanding.

It highlights the role of intracoronary imaging in refining procedural planning and optimising stenting strategy and technique. The discussion also reviews the mechanical...

Left main and complex bifurcation stenting

The right therapy for right heart failure and tricuspid regurgitation: fixing my patient congestion, not just a valve

21 May 2026 – From EuroPCR 2026

This EuroPCR 2026 session shifts the focus in tricuspid regurgitation from anatomy alone to the broader context of right heart failure and systemic congestion. It highlights the limitations of purely leaflet-based strategies, particularly in advanced disease and in the presence of severe right ventricular dysfunction.

The discussion...

The right therapy for right heart failure and tricuspid regurgitation: fixing my patient congestion, not just a valve

Aortic regurgitation in 2026

21 May 2026 – From EuroPCR 2026

Get a comprehensive overview of contemporary management strategies for aortic regurgitation, a condition that remains frequently underdiagnosed and undertreated despite significant advances in transcatheter therapies thanks to this EuroPCR 2026 session.

The programme reviews current diagnostic and treatment pathways, including guideline-based management and the role of surgical...

LDL-C management: should it begin in the cathlab?

21 May 2026 – From EuroPCR 2026

This EuroPCR 2026 session examines the evolving role of LDL cholesterol management in patients undergoing percutaneous coronary intervention (PCI), with a focus on the potential benefits of initiating intensive lipid-lowering strategies early in the patient pathway.

The discussion reviews emerging evidence on PCSK9 inhibition in elective PCI...

LDL-C management: should it begin in the cathlab?

Active unloading with Impella heart pumps in elective and emergent patients

21 May 2026 – From EuroPCR 2026

This session presents the latest evidence on the use of microaxial Impella heart pumps in both elective high-risk and emergent cardiogenic shock patients. It highlights the importance of organised systems of care in improving survival outcomes and explores current data and expert consensus on mechanical circulatory...

Active unloading with Impella heart pumps in elective and emergent patients

Ascending into the future with drug-coated balloons

21 May 2026 – From EuroPCR 2026

Step into the future of interventional cardiology with comprehensive insights into drug‑coated balloons (DCB). This session covers the new DCB ARC guidelines, previews findings from the impactful BASKET BALL randomised trial, and examines real-world evidence from the SCORE registry. It also addresses the optimisation of acute...

Ascending into future with drug-coated balloons

IVUS and NIRS imaging: a pathway to improve outcomes in stable and acute coronary syndromes

19 May 2026 – From EuroPCR 2026

IVUS-guided PCI is well established in complex coronary interventions, but combining it with near-infrared spectroscopy (NIRS) is opening a new dimension by linking vessel geometry with plaque biology.

This EuroPCR 2026session explores how IVUS-NIRS imaging improves PCI planning and risk stratification in both stable and acute coronary...

IVUS and NIRS imaging: a pathway to improve outcomes in stable and acute coronary syndromes

CathWorks FFRangio: from clinical data to advanced patient care

21 May 2026 – From EuroPCR 2026

Explore the clinical value of the CathWorks FFRangio system through the lens of the ALL-RISE randomised controlled trial and its implications for daily practice. By reviewing the trial’s primary and secondary endpoints, examine how FFRangio may influence diagnostic assessment, treatment planning, and clinical decision-making in patients...